250275-15-1

基本信息
順式-2-BOC-六氫吡咯并[3,4-C]吡咯
內(nèi)消旋-2-BOC-八氫吡咯[3,4-C]吡咯
cis-2-Boc-六氫吡咯并[3,4-c]吡咯
順式-2-BOC-六氫吡咯并[3,4-C]吡咯 1G
cis-六氫吡咯并[3,4-c]吡咯-2-羧酸叔丁酯
順式-叔丁基六氫吡咯并[3,4-C]吡咯-2(1H)-甲酸叔丁酯
(3AR,6AS)-叔丁基六氫吡咯并[3,4-C]吡咯-2(1H)-羧酸酯
2-BOC-HEXAHYDROPYRROLO[3,4-C]PYRROLE, CIS
cis-2-Boc-hexahydropyrrolo[3
-Boc-hexahydropyrrolo[3,4-c]pyrrole
3-Boc-3,7-diazabicyclo[3.3.0]octane
Cis-2-Boc-hexahydropyrrol-3,4-cpyrrole
cis-3-Boc-3,7-diazabicyclo[3.3.0]octane
CIS-2-BOC-HEXAHYDROPYRROLO[3,4-C]PYRROLE
2-boc-hexahydropyrrolo[3,4-c]pyrrole, cis
cis-3,7-Diazabicyclo[3.3.0]octane, N3-BOC protected
2-(tert-Butoxycarbonyl)hexahydropyrrolo[3,4-c]pyrrole
物理化學(xué)性質(zhì)
制備方法

370879-56-4
![cis-2-Boc-六氫吡咯并[3,4-c]吡咯](/CAS/GIF/250275-15-1.gif)
250275-15-1
以順式-5-芐基六氫吡咯并[3,4-c]吡咯-2(1H)-羧酸叔丁酯為原料合成順式-叔丁基六氫吡咯并[3,4-c]吡咯-2(1H)-甲酸叔丁酯的一般步驟:向(3aR,6aS)-5-芐基六氫吡咯并[3,4-c]吡咯-2(1H)-羧酸叔丁酯(5g,16.5mmol)的甲醇(50mL)溶液中加入10% Pd(OH)2/C催化劑(0.5g)。將反應(yīng)混合物置于氫氣氛圍(60psi)下,60℃攪拌過夜,隨后冷卻至室溫。反應(yīng)混合物經(jīng)硅藻土過濾,濾液經(jīng)減壓濃縮,得到(3R,6aS)-六氫吡咯并[3,4-c]吡咯-2(1H)-羧酸叔丁酯,為無色油狀物(2.3g,收率66%)。
參考文獻(xiàn):
[1] Patent: US2002/19388, 2002, A1
[2] Patent: WO2015/120049, 2015, A1. Location in patent: Page/Page column 139; 140
[3] Patent: WO2016/191172, 2016, A1. Location in patent: Page/Page column 86
[4] Patent: US2009/281118, 2009, A1. Location in patent: Page/Page column 10
[5] Journal of Medicinal Chemistry, 2009, vol. 52, # 14, p. 4126 - 4141
常見問題列表
cis-2-Boc-六氫吡咯并[3,4-c]吡咯是一種藥物合成中間體,可由N-(甲氧基甲基)-N-三甲基甲硅烷基甲基)芐胺和N-芐基馬來酰亞胺為原料,通過六步反應(yīng)制備得到。